GlassScriptPhysician profile
Rebecca E Melvin
NPI 1609079409
$1,703.39
in general payments reported to CMS, 2019-2025
36 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.70 · 2022: $489 · 2023: $522 · 2024: $135 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.40 | 2021-2025 | |
| Lilly USA, LLC | $125.77 | 2022-2025 | Zepbound, Mounjaro, Emgality |
| Supernus Pharmaceuticals, INC. | $77.50 | 2023-2025 | Qelbree, Qelbree |
| Amgen INC. | $75.40 | 2023-2025 | Otezla, Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $70.19 | 2021-2025 | |
| Pfizer INC. | $68.12 | 2023-2025 | |
| Sanofi Pasteur INC. | $63.65 | 2022-2024 | |
| Novo Nordisk INC | $59.62 | 2023-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $57.88 | 2022-2025 | Shingrix, Bexsero, Rotarix |
| Lundbeck LLC | $56.75 | 2025 | Rexulti, Vyepti |
| Corcept Therapeutics | $50.00 | 2023 | Korlym |
| Exact Sciences Corporation | $47.27 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $41.56 | 2025 | Auvelity |
| Neos Therapeutics, LP | $39.96 | 2023-2025 | Adzenys Xr-Odt |
| Tris Pharma INC | $38.98 | 2022-2023 | Dyanavel Xr |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $33.63 | 2022 | |
| Merck Sharp & Dohme LLC | $32.48 | 2023 | Vaxneuvance, Pneumovax 23, Vaxelis |
| Cranial Technologies, INC | $31.21 | 2022 | |
| Globus Medical, INC. | $29.16 | 2025 | Senza |
| Radius Health, INC. | $26.06 | 2025 | Tymlos |
| Nevro Corp. | $25.05 | 2022 | |
| Sumitomo Pharma America, INC. | $22.78 | 2023 | Gemtesa |
| Itamar Medical INC | $22.51 | 2025 | Watchpatone |
| Boston Scientific Corporation | $21.69 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.60 | 2025 | Jardiance |
| Antares Pharma, INC. | $19.92 | 2022 | |
| Seqirus USA INC | $19.62 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.91 | 2025 | Jornay Pm |
| Abbott Laboratories | $17.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.88 | 2023 | |
| Daiichi Sankyo INC. | $17.12 | 2022 | |
| Neurelis, INC. | $16.44 | 2023 | Valtoco |
| Ironshore Pharmaceuticals INC. | $16.40 | 2024 | |
| Noven Therapeutics, LLC | $15.71 | 2024 | Xelstrym |
| Astrazeneca Pharmaceuticals LP | $13.36 | 2022 | |
| Ucb, INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Melvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.